THERESA GERMANO: Open Payments
NPI 1740839273 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 100 payments from 17 companies in 2025. Trend: 2023 $1,794 · 2024 $1,903 · 2025 $2,116
Food & beverage: $2,116
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $462 |
| Madrigal Pharmaceuticals | 18 | $321 |
| Phathom Pharmaceuticals, Inc. | 5 | $297 |
| Lilly USA, LLC | 16 | $287 |
| Novo Nordisk Inc | 13 | $188 |
| ABBVIE INC. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| PFIZER INC. | 3 | $58 |
| QOL Medical, LLC | 3 | $58 |
Products named: TREMFYA, REZDIFFRA, VOQUEZNA, JARDIANCE, ZEPBOUND, Wegovy, XIFAXAN, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
